Javascript required
Skip to content Skip to sidebar Skip to footer

Mens Ariat 11 Workhog Venttek Ct Sku Art10020091120m Bruin Brown Stone 12 Medium

Adjunct membership is for researchers employed past other institutions who collaborate with IDM Members to the extent that some of their own staff and/or postgraduate students may work inside the IDM; for 3-year terms, which are renewable.


BARRY III, Dr Clifton
PhD, Section Primary and Senior Investigator, Tuberculosis Research Section (TRS), National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health (NIH).

Areas of involvement span the basic sciences of chemistry, biochemistry and microbiology, through to pharmacology and clinical medicine, in the areas of mycobacterial pathogenesis and TB drug discovery research.

email


BROWN, Prof Gordon
PhD, FRS, FMedSci, FRSB, FAAM, FRSE, RSSAf, Director MRC Centre for Medical Mycology at the University of Exeter and Manager of the AFGrica Unit at The University of Cape Boondocks (UCT). Honorary Professor at UCT.

His primary enquiry interests are C-type lectin receptors and their role in homeostasis and amnesty, with a item focus on antifungal amnesty.

email


Grayness, Prof Clive
Professor Emeritus of Immunology, Division of Immunology, Department of Pathology, University of Greatcoat Boondocks; Professor of Immunology in Molecular Biology and Human Genetics, Stellenbosch University, Cape Town; Offshoot Professor, Section of Immunology, Knuckles University, North Carolina, Us; Secretary-General, Federation of African Immunology Societies; Vice-Chair, Education Commission of the IUIS; Managing director of the Immunopaedia Foundation.

His research interests circumduct around investigating allowed regulation and dysregulation in the context of HIV infection or exposure. He focuses on Immune ontogeny in HIV exposed infants, placental investigations and pre-term birth, and epithelial immunity in the foreskin. He has an agile group inside the IDM and is based at Stellenbosch Academy where he directs the Reproductive Immunology Inquiry Consortium in Africa (RIRCA). He is the past Chair of Immunology at UCT and holder of several NIH and European-based grants.

email


Grey, Prof Glenda
MBBCH, FCP (Paeds) SA. Executive Director Perinatal HIV Research Unit, Wits Health Consortium, Academy of Witwatersrand; Acquaintance Professor, Department of Paediatrics, Academy of Witwatersrand, South Africa; HVTN Managing director of International Programmes; HVTN Co-Principal Investigator; Chair of the standing committee on Health, ASSAF.

Her Inquiry Unit of measurement is involved with clinical inquiry, epidemiology and operational inquiry, and is a treatment site for HIV infected adults and children. Her research interests include HIV vaccine inquiry, microbicide research and other biomedical and behavioural interventions, and she is an investigator in testing two HIV vaccine regimens in late stage clinical evolution. Her TB research includes examining new agents to prevent TB, TB prophylaxis and TB vaccine evaluation.

email


GROBUSCH, Prof Martin
Professor, Dr. Med. (M.D.), PhD, 1000.Sc. (Lond), DTM&H (Lond), FRCP (Lond). Specialist in Internal Medicine, Infectious Diseases, Tropical Medicine. Total Professor and Chair of Tropical Medicine and Travel Medicine and Head, Heart of Tropical Medicine and Travel Medicine, Amsterdam Medical Centre, Academy of Amsterdam in the Netherlands.

He has been an author on over 150 manuscripts in the field of infectious diseases and has an extensive track record in infectious diseases inquiry and practise covering clinical, laboratory and epidemiological aspects.

email


LESLIE, Dr Al
Main investigator Africa Health Research Institute (AHRI), Durban, Due south Africa; Acquaintance Professor, Academy of KwaZulu Natal, Durban, S Africa; Wellcome Trust senior Boyfriend, section of infection and amnesty, Academy Higher London, United kingdom of great britain and northern ireland.

He is an HIV and TB immunologist focused on studying the immune response to these pathogens in affected tissues, and how this relates to what can exist observed from the blood. The research goal is to improve understanding of the immunopathology of TB and HIV, using this information to aid in developing novel therapeutic approaches and diagnostic biomarkers.

email


LEWINSOHN , Prof Dave

MD, PhD, Professor and Vice Chair for Research, Section of Medicine, Manager OHSU Center for Global Child Health Inquiry, Department of Pediatrics.

His inquiry has centered on agreement the mechanisms by which the human allowed organization recognises the Mycobacterium tuberculosis (M.tb) infected jail cell. This inquiry has focused largely on CD8+ T cells, with a focus on both those antigens that are recognised, and the means past which they are presented. His work has a strong translational component, request if both classically and non-classically restricted T cells are associated with infection with One thousand. tb, reflect immunological memory, and are enriched at the site of infection.

email


LEWINSOHN, Prof Deborah

MD, Professor, and Vice Chair for Inquiry, Sectionalisation Head Infectious disease, Wayne L. Tracy Professor of Infectious Illness, Section of Pediatrics, Assistant Director, OHSU Center for Global Child Health Research.

Her research focuses on understanding the role of the developing immune system on the susceptibility of young children to tuberculosis (TB) and understanding the role of innate and adaptively acquired CD8+ T cells in host defense to TB. The translational significance of this enquiry is centred on informing the development of novel vaccines and diagnostics for childhood TB.

email


MOORE, A/Prof Penny
South African Inquiry Chair in Viral Host Dynamics, Faculty of Health Sciences, Academy of Witwatersrand and National Institute for Communicable diseases.

Her current enquiry focuses on HIV broadly neutralising antibodies and their interplay with the evolving virus. Recent studies published in PloS Pathogens, Nature and Nature Medicine take highlighted the role of viral escape in creating new epitopes and immunotypes, thereby driving the development of neutralisation latitude, with implications for HIV vaccine blueprint.

email


NICOL, Prof Mark
School of Biomedical Sciences, Division of Infection and Immunity, University of Western Australia; Professor in Microbiology.

Research interest in tuberculosis and in developing and testing point of intendance diagnostics suitable for the developing world.

email


REDD, Dr Andrew
PhD, Staff Scientist in International HIV and STD Department, National Institute of Allergy and Infectious Diseases at the Us National Institutes of Health; Assistant Professor of Medicine at Johns Hopkins Academy.

His inquiry is focused on amend understanding HIV manual and disease dynamics with a special concentration on HIV superinfection, latent HIV infection, and the function of the virus in HIV+ organ transplantation.

email


WILKINSON, A/Prof Katalin
Principal Research Scientist at The Francis Crick Institute London; Honorary Associate Professor, Partitioning of Infection and Immunity, Academy College London; Honorary Associate Professor, Department of Medicine, University of Cape Boondocks.

Her research focuses on the immunology of HIV-associated tuberculosis (TB). More specifically, the reconstitution of the immune response during antiretroviral treatment, in order to place correlates of protection (including allowed mechanisms that lead to reduced susceptibility to TB), and pathogenesis (such as the Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, TB-IRIS); the biosignature of the TB infection spectrum, from latent infection to active disease; preventing TB infection in HIV infected people more effectively; and the pathogenesis of tuberculous meningitis and pericarditis.

email

vrolandfinced.blogspot.com

Source: http://www.idm.uct.ac.za/Adjunct_Members